Labshake search
Citations for Stemcell Technologies :
1 - 50 of 1202 citations for Carbamic acid 2 4 hexadienyl 1 1 dimethylethyl ester E E 9ci since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... Compound E (0.1 μM; STEMCELL Technologies), db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2023Quote: ... and Compound E (73952, StemCell Technologies) using the protocol 26 ...
-
bioRxiv - Neuroscience 2022Quote: ... 0.1 µM Compound-E (StemCell Technologies), 2ng/mL BDNF ...
-
bioRxiv - Neuroscience 2024Quote: ... Compound E (StemCell Technologies Vancouver, Canada) was exchanged every 48 to 72 hours with every other media change containing 1 ug/mL laminin (ThermoFisher) ...
-
bioRxiv - Cell Biology 2022Quote: ... Compound E (0.1 μM; STEMCELL Technologies; 73954), db-cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2022Quote: ... 0.2 µM Compound E (Stem Cell Technologies), 1 µg/mL Laminin (R&D ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 µM Compound E (Stem Cell Technologies). On day 3 ...
-
bioRxiv - Neuroscience 2021Quote: ... 2mM Dorsomorphin (Miltenyi) and 0.1mM Compound E (StemCell Technologies). Medium was changed daily for 2 days ...
-
bioRxiv - Neuroscience 2024Quote: ... 0.1 µM Compound E (CpdE, StemCell Technologies; Cat#73954), and 10 ng/ml insulin-like growth factor-1 (IGF-1 ...
-
bioRxiv - Immunology 2020Quote: ... and cells from wells with reactive supernatants were expanded to 48-well plates for 1 week in 0.5 mL of StemCell medium E (StemCell Technologies), before being screened again by ELISA ...
-
bioRxiv - Immunology 2022Quote: ... and cells from wells with reactive supernatants were expanded to 48-well plates for 1 week in 0.5 mL of StemCell medium E (StemCell Technologies), before being screened again by ELISA ...
-
bioRxiv - Immunology 2021Quote: ... CD34+ umbilical cord and CD34+ hematopoietic stem/progenitor cell (Ethics Committee Salzburg approval 415-E/1776/4-2014) were isolated using density gradient centrifugation (Lymphoprep; Stemcell Technologies). Primary human cells ...
-
bioRxiv - Immunology 2021Quote: ... Hybridomas were thawed and expanded in ClonaCell-HY Growth Medium E (Stem Cell Technologies) up to a volume of 300ml ...
-
bioRxiv - Immunology 2021Quote: The 7D9 hybridoma line was cultured in ClonaCell™-HY Medium E (STEMCELL Technologies) prior to antibody production ...
-
Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localizationbioRxiv - Neuroscience 2023Quote: ... 1 µM retinoic acid (72264, Stemcell Technologies) was added to the medium ...
-
bioRxiv - Developmental Biology 2023Quote: ... differentiating cells were confluent again and split 1:3-1:4 into Step 2 differentiation medium: BrainPhys Neuronal Medium (STEMCELL Technologies, cat# 05790), 1X N2 ...
-
bioRxiv - Immunology 2021Quote: ... The selected cloned cell lines secreting mAb H5.28 or H5.31 were grown initially in hybridoma growth medium (ClonaCell-HY medium E from STEMCELL Technologies). Prior to antibody expression and purification ...
-
bioRxiv - Developmental Biology 2024Quote: ... 0.5 μM 1-Oleoyl Lysophosphatidic Acid (LPA; STEMCELL Technologies, 72694), 10 ng/mL LIF ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 1 μM valproic acid (VPA; HDACi; STEMCELL Technologies, 72292). After three days in this medium ...
-
bioRxiv - Neuroscience 2024Quote: ... SH-SY5Y cells were counted and seeded at a density of 10.4 × 103 cells/cm2 in differentiation media (Neurobasal medium, 2% B27 supplement, 1% GlutaMAX, and 10 μM of all-trans retinoic acid [STEMCELL Technologies]). Differentiation media was replaced every other day until day 9 post-seeding ...
-
bioRxiv - Bioengineering 2021Quote: ... then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Neuroscience 2024Quote: ... 1% minimum essential medium/non-essential amino acid (Stem Cell Technologies), 1% penicillin/streptomycin (Thermo Fisher Scientific) ...
-
bioRxiv - Neuroscience 2024Quote: ... 1% minimum essential medium/non-essential amino acid (Stem Cell Technologies), 20 ng/ml brain-derived neurotrophic factor (ProSpec Bio) ...
-
bioRxiv - Neuroscience 2024Quote: ... in a feeder free fashion and passaged every 4∼5 days at a 1:4∼1:6 ratio using ReLeSR (Stemcell technologies) as described previously 88,95 ...
-
bioRxiv - Bioengineering 2021Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 % neomycin and addition of 10 μM retinoic acid (RA) (Stemcell Technologies). At day 6 the cells were washed twice with warm PBS (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: ... On day 3 cells were changed into a 50/50 ratio of fibroblast media and TeSR™ E-7™ Reprogramming Media (STEMCELL Technologies), and on day 5 were changed into 100% E-7™ Reprogramming Media ...
-
bioRxiv - Immunology 2024Quote: ... were differentiated into TH2 T cell subtype by incubation with specific supplement for TH2 differentiation (mouse IL-2, mouse IL-4 and rat anti mouse IFNγ with 1:100 dilution (STEMCELL Technologies)) and incubated for 3 days on plates coated with aCD3 and aCD28 antibodies ...
-
bioRxiv - Neuroscience 2022Quote: ... were passaged 1:4 using ACCUTASE™ (Stemcell technologies, 07920) when confluent and subsequently grown in Astrocyte medium containing leukemia inhibitory factor (LIF ...
-
bioRxiv - Neuroscience 2020Quote: ... Dibutyryl-cAMP (1 mM) and ascorbic acid (200 nM) (STEMCELL Technologies, Vancouver, BC, Canada). Half fresh medium containing Amyloid β Protein Fragment 1-42 (50 nM ...
-
bioRxiv - Genomics 2020Quote: ... Tissues were minced into ~1-2 mm pieces and digested with 1× Collagenase/Hyaluronidase (STEMCELL Technologies) and 100 μg/mL DNase I (Sigma-Aldrich ...
-
bioRxiv - Genomics 2021Quote: Tissues were minced into ~1-2 mm pieces and digested with 1× Collagenase/Hyaluronidase (STEMCELL Technologies) and 100 μg/mL DNase I (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... on day 2 media was changed to Neurobasal A and DMEM/F12 1:1 (Stemcell technologies) supplemented with N2 0.5% ...
-
bioRxiv - Neuroscience 2022Quote: ... human PDGF-AA (10 ng ml−1) and PDGF-BB (10 ng ml−1; Shenandoah) and heparin (2 ng ml−1; Stem Cell Technologies). For all patient-derived cultures ...
-
bioRxiv - Genomics 2024Quote: ... HPCs were plated at 22,000 cells/cm2 onto a Matrigel-coated 6-well plate containing 2ml of Microglia differentiation medium (Basal Medium with supplement 1 and 2 at 1:9 and 1:225, respectively; STEMCELL Technologies, #100-0019). Cells were supplemented with fresh half-medium every other day from day 0 to day 10 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Tissues were minced into ∼1–2 mm pieces before digesting with 1 × Collagenase/Hyaluronidase (STEMCELL Technologies, Catalog #: 07912) and 100 μg/mL DNase I (Sigma Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: ... Each plate was then split 1:2 using ReLeSR (StemCell Technologies), with half of the cells used for DNA extraction for Sanger sequencing ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of 1 μg/L of human interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Cell Biology 2022Quote: ... Cells were split by dissociating to small clusters and replating at a 1:3-1:4 ratio using ReLeSR (StemCell Technologies) once cell clusters reached ∼70% coverage of the culture surface ...
-
bioRxiv - Cell Biology 2024Quote: ... iPSCs were passaged with Versene solution (Paneco, Russia) at a ratio of 1:15 – 1:20 every 4–5 days with ROCK-inhibitor (StemCell Technologies).
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged 1-2 times per week with ReLeSR (STEMCELL Technologies) when they reached 80-90% confluence ...
-
bioRxiv - Genomics 2024Quote: ... cells were resuspended with 1-2 mL Dispase (Stem Cell Technologies, 07923) and 200 µL 1mg/mL DNase I (Stem Cell Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... and routinely split 1-2 times a week with ReLeSR (STEMCELL Technologies) without ROCKi (Y-27632 ...
-
bioRxiv - Cell Biology 2024Quote: ... iPSCs were passaged with Versene solution (Paneco, Russia) at a ratio of 1:15 – 1:20 every 4–5 days with ROCK-inhibitor (Stem Cell Technologies).
-
bioRxiv - Cancer Biology 2023Quote: ... bone marrow aspirates were diluted 1:1 with PBS (+ 2% FBS) and layered on a Lymphoprep gradient using SepMate tubes (STEMCELL Technologies). After centrifugation ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1), 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF ...
-
bioRxiv - Immunology 2023Quote: ... Isolated cells were cultured for 1-2 weeks in StemSpan Medium (Stemcell Technologies) supplemented with 10 ng/ml interleukin (IL)-3 ...
-
bioRxiv - Genomics 2024Quote: ... then cells were replated 1:2 in STEMdiff Neural Progenitor Medium (Stemcell Technologies) for NPC expansion.
-
bioRxiv - Bioengineering 2023Quote: ... Stages 1 and 2 used basal media comprised of 1:1 mixture RPMI and DMEM F-12 supplemented with BSA and SM1 (Stem Cell Technology) or B27 (ThermoFisher ...